Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Non-valvular Atrial Fibrillation (NVAF) Patients with Diabetes in a US Population

Autor:	Jeffrey S. Berger, Veronica Ashton, François Laliberté, Guillaume Germain, Brahim Bookhart, Dominique Lejeune, Julien Boudreau, Patrick Lefebvre, Matthew R. Weir
Rok vydání:	2023
Předmět:	Pharmacology (medical) General Medicine
Zdroj:	Advances in Therapy. 40:1224-1241
ISSN:	1865-8652 0741-238X
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d2960b3b4f809befbc997b4ccb543e7a https://doi.org/10.1007/s12325-022-02422-9 Zobrazit plný text záznamu Full text from SpringerLink